BUFFALO, NY – Roswell Park Cancer Institute (RPCI) physician Roberto Pili, MD, has been awarded an R01 grant from the National Institutes of Health to study the role of histone deacetylase (HDAC) inhibitors in treating renal cell carcinoma (RCC). The two-year grant is for $675,000.
BUFFALO, NY - As the nation commemorates National Breast Cancer Awareness Month, Roswell Park Cancer Institute (RPCI) today announced the establishment of a $1.5 million endowed fund in Breast Oncology from the Alfiero Family Charitable Foundation of Western New York.
Buffalo, NY - Roswell Park Cancer Institute (RPCI) has received a $2.1M National Institutes of Health grant to assess smokers' interest in smokeless tobacco products. Richard O'Connor, PhD, of the Health Behavior Department at RPCI, is the principal investigator.
BUFFALO, NY - Roswell Park Cancer Institute (RPCI) has licensed its photodynamic therapy (PDT) technology to pharmaceutical companies in India and China, reports Richard Matner, PhD, MBA, Director of RPCI's Technology Transfer Office.
BUFFALO, NY – Roswell Park Cancer Institute (RPCI) will host the third annual Dr. Enrico Mihich lecture series on Wednesday, October 14, at 8 am in the Zebro Conference Room, Center for Genetics and Pharmacology, on the main RPCI campus.